Trenbolone

A veterinary cattle implant that became the most feared and most meme'd steroid in bodybuilding — dramatic recomposition, and a side-effect profile severe enough that "tren dreams" and "tren rage" are community vocabulary, not marketing.

Trenbolone binds the androgen receptor several times more strongly than testosterone does, and unlike almost everything else in this class it cannot be aromatised at all — there is no estrogen pathway from trenbolone, full stop. That fact is the source of both its reputation and its worst misunderstanding. It is progestogenic instead, and progesterone-receptor activity can drive prolactin-mediated effects that look exactly like estrogenic ones. It is also not meaningfully converted by 5-alpha reductase, so it reaches tissue as the potent parent compound. Beyond receptor binding it is a nutrient-partitioning agent — the reason cattle feedlots used it in the first place was feed efficiency, converting intake into lean tissue rather than fat.

Zero human clinical development — every human data point is animal agriculture, case reports, or the community. Its potency at the androgen receptor is real (several times testosterone), which is precisely why the harms arrive at the same scale.

• There is none. Not "thin," not "preclinical-only" — trenbolone has never been developed for human use in any formal programme, so there is no human trial of any size, phase or quality to summarise.
• The entire evidence base is livestock production data (where the endpoints are carcass yield and feed conversion, not human health) plus veterinary pharmacology.
• Everything else circulating about it — the strength claims, the recomposition claims, the comparative potency numbers — is receptor-binding-affinity data extrapolated into human outcomes it was never measured against, plus self-report.
• The neuropsychiatric effects are the most consistently reported phenomenon associated with it, and they too rest on user report and case description rather than controlled study, which means the true frequency is genuinely unknown.

Several ester forms circulate and differ substantially in release and elimination; because it is neither aromatised nor 5-alpha reduced, what reaches tissue is essentially the parent compound, and adverse effects and endocrine suppression can outlast measurable drug. Trenbolone metabolites are readily detected in anti-doping testing well after use. Its distinctive effects — night sweats, sleep disruption, the cough some people get immediately on injection — track the compound itself rather than any metabolite.

Night sweats, insomnia, aggression and anxiety, dyspnea ("tren cough"), crushed cardio capacity, severe lipid damage, prolactin-adjacent effects, and a notorious mental-health footprint. No aromatization but its own estrogen-axis weirdness. Recovery of natural production after tren runs is among the slowest reported. There is no medical oversight pathway for a veterinary compound — bloodwork is the only instrument anyone has.

• Anyone with any history of depression, anxiety, psychosis or mood instability — this is the compound in this catalog with the most consistent neuropsychiatric signal.
• Anyone with cardiovascular disease, hypertension, or an already adverse lipid profile.
• Anyone with impaired kidney function.
• Anyone whose sleep is already poor, or whose work and relationships cannot absorb months of irritability and broken sleep.
• Anyone drug-tested at any level of sport.

• Aromatase inhibitors do nothing useful against trenbolone-driven breast tissue changes, because the pathway is prolactin/progesterone rather than estrogen — a mismatch that leads people to escalate a drug that was never going to work.
• Stimulants, caffeine included, stack onto an already elevated heart rate, blood pressure and insomnia load.
• Any other compound that raises prolactin compounds the same problem.
• Combining it with other non-aromatising compounds can drive estradiol low enough that libido and joint symptoms arrive from the deficit rather than any excess.

• Prolactin — the single most relevant lab here, and the one people skip because they are watching estrogen, which trenbolone does not produce.
• Lipids — HDL suppression with trenbolone is severe even by anabolic-steroid standards.
• Blood pressure, measured at home and often.
• Kidney markers (creatinine, eGFR, urinalysis) — dark urine is commonly reported; some of that is muscle-breakdown product rather than kidney injury, but telling those apart requires a test, not a guess.
• Sleep quality and mood, tracked honestly and ideally corroborated by someone else — insomnia and irritability are the effects users are least able to self-assess.
• Full hormone panel including LH/FSH, given the depth of suppression.

Suppression is profound and the recovery window is correspondingly rough — the low-testosterone state that follows lands on top of whatever sleep debt and mood disturbance accumulated during use. Night sweats and insomnia typically resolve as the compound clears, on the ester's timeline. The axis is the unpredictable part: heavy or prolonged use here produces some of the slower recoveries in this class, and there is no human data to give an expected duration — only the pattern clinicians describe afterwards.

US: Schedule III. Human use is entirely underground; the raw supply is cattle-implant conversions.

• Impact of trenbolone on selected organsEndokrynol Pol · 2024
• Trenbolone: application of the Ames test. Recent dataAnn Rech Vet · 1991
• Environmental fate and effects of 17α-trenbolone and 17α-estradiol: IntroductionEnviron Toxicol Chem · 2017
• Melatonin attenuates 17β-trenbolone induced insomnia-like phenotype and movement deficiency in zebrafishChemosphere · 2020
• 17β-Trenbolone activates androgen receptor, upregulates transforming growth factor beta/bone morphogenetic protein and Wnt signaling pathways, and induces masculinization of caudal and anal fins in female guppies (Poecilia reticulata)Aquat Toxicol · 2023
• Examining the association between trenbolone, psychological distress, and aggression among males who use anabolic-androgenic steroidsInt J Drug Policy · 2024
• 17β-Trenbolone binds to androgen receptor, decreases number of primordial germ cells, modulates expression of genes related to sexual differentiation, and affects sexual differentiation in zebrafish (Danio rerio)Sci Total Environ · 2022
• Influence of Bisphenol A and 17β-Trenbolone Exposure in Oryzias CongenersEnviron Toxicol Chem · 2023
• Localized surface plasmon resonance sensing of Trenbolone acetate dopant using silver nanoparticlesSci Rep · 2024
• Effect of 17β-trenbolone exposure during adolescence on the circadian rhythm in male miceChemosphere · 2022
• Transcriptomic profiling as a screening tool to detect trenbolone treatment in beef cattleRes Vet Sci · 2014
• Sorption and desorption of 17α-trenbolone and trendione on five soilsEnviron Toxicol Chem · 2017